Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 941 (LINC00941) is a human long non-coding RNA (lncRNA) located at chromosome 12p11.21[1]. It is also referred to as lncRNA-MUF, MSC upregulated factor, and several other aliases. LINC00941 is implicated in the regulation of cell proliferation, migration, adhesion, and extracellular matrix organization, primarily through gene expression and co-expression module networks in various cancers, including gastric cancer, hepatocellular carcinoma, and lung adenocarcinoma[1]. Experimental studies show that LINC00941 silencing inhibits cancer cell proliferation, migration, and invasion, with in vivo evidence for its role in tumor growth and metastasis[1]. LINC00941 also serves as a repressor of keratinocyte differentiation, thereby playing a key role in epidermal tissue homeostasis and preventing premature differentiation in the skin[2]. While it is emerging as a potential diagnostic and prognostic biomarker in certain cancers, no direct drugs or targeted therapeutics are documented for LINC00941 to date, and it is not classified as a traditional druggable therapeutic target such as a receptor or enzyme[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 941 (LINC00941).